3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Recurrence
2
Osteosarcoma
2
Hematologic Neoplasms
2
Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neurofibrosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Myelodysplastic Syndromes
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphoid
1
Leukemia, Large Granular Lymphocytic
1
Leukemia, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hepatoblastoma
1
Desmoplastic Small Round Cell Tumor
1
Carcinoma
1
Burkitt Lymphoma
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Interventions
Radiotherapy
5
Oxaliplatin
5
Nivolumab
5
Fluorouracil
5
Cetuximab
5
Leucovorin
4
Magnetic Resonance Spectroscopy
3
Bevacizumab
3
sintilimab
2
pembrolizumab
2
fludarabine
2
encorafenib
2
aldesleukin
2
Tomography, X-Ray Computed
2
Specimen Handling
2
Pemetrexed
2
Magnetic Resonance Imaging
2
Irinotecan
2
Gemcitabine
2
Folfox protocol
2
Electrocardiography
2
Drug Therapy
2
Dexamethasone
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
Biopsy
2
ulixertinib
1
trifluridine tipiracil drug combination
1
trastuzumab biosimilar HLX02
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Mesna
×
30 days
×
Clear all
No trials found.